Diarrhea Global Clinical Trials Review, H1, 2012

GlobalData
March 27, 2012
113 Pages - SKU: GBDT3824157
Countries covered: Global

Diarrhea Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2012 provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diarrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Diarrhea Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Diarrhea , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.



More Ophthalmology reports by GlobalData

EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023 by GlobalData
EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023SummaryAge-related macular degeneration (AMD) is a progressive eye condition caused by the gradual deterioration of the ...
Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014 by GlobalData
Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014 provides data ...
Uveitis Global Clinical Trials Review, H2, 2013 by GlobalData
Uveitis Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2013 provides data on the Uveitis clinical trial ...
OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 by GlobalData
OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017SummaryUveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and ...
See all reports like this >>

More Global Ophthalmology reports

Global Cytomegalovirus Retinitis Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Cytomegalovirus Retinitis Market 2014-2018 TechNavio recognizes the following companies as the key players in ...
Global Retinal Vein Occlusion Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Retinal Vein Occlusion Market 2014-2018TechNavio recognizes the following companies as the key players in ...
Global Ophthalmic Diagnostic Devices Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Ophthalmic Diagnostic Devices Market 2014-2018TechNavio recognizes the following companies as the key players in ...
Global Macular Edema Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Macular Edema Market 2014-2018TechNavio recognizes the following companies as the key players in the ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,000  
    Global Site License  USD 3,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!